The PE Ratio as of December 2024 (TTM) for NeuroSense Therapeutics Ltd. (NRSN) is -1.68

According to NeuroSense Therapeutics Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -1.68. This represents a change of -37.10% compared to the average of -2.67 of the last 4 quarters.

NeuroSense Therapeutics Ltd. (NRSN) Historical PE Ratio (quarterly & annually)

How has NRSN PE Ratio performed in the past?

The mean historical PE Ratio of NeuroSense Therapeutics Ltd. over the last ten years is -2.68. The current -1.68 PE Ratio has changed 6.17% with respect to the historical average. Over the past ten years (40 quarters), NRSN's PE Ratio was at its highest in in the September 2023 quarter at 3.08. The PE Ratio was at its lowest in in the December 2021 quarter at -66.64.

NeuroSense Therapeutics Ltd. (NRSN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NeuroSense Therapeutics Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeuroSense Therapeutics Ltd. (NRSN) Average PE Ratio

How has NRSN PE Ratio performed in the past?

The current PE Ratio of NeuroSense Therapeutics Ltd. (NRSN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NeuroSense Therapeutics Ltd. (NRSN) PE Ratio vs. Peers

How is NRSN’s PE Ratio compared to its peers?

NeuroSense Therapeutics Ltd.’s PE Ratio is less than Quoin Pharmaceuticals, Ltd. (-0.28), less than Revelation Biosciences, Inc. (-0.05), less than Hillstream BioPharma, Inc. (-0.99), less than NeuroBo Pharmaceuticals, Inc. (-0.87), less than Virax Biolabs Group Limited (-0.57), greater than Nutriband Inc. (-6.31), less than Longeveron Inc. (-1.34), greater than RenovoRx, Inc. (-3.51), less than Blue Water Vaccines, Inc. (-0.01), less than Kiora Pharmaceuticals, Inc. (2.50), less than PaxMedica, Inc. Common Stock (-0.03), less than Allarity Therapeutics, Inc. (-0.08), less than Kiromic BioPharma, Inc. (-1.17), less than Biodexa Pharmaceuticals Plc (-0.16),

Build a custom stock screener for NeuroSense Therapeutics Ltd. (NRSN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroSense Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroSense Therapeutics Ltd. (NRSN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroSense Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.